BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 9265913)

  • 1. The biological basis of schizophrenia: new directions.
    Weinberger DR
    J Clin Psychiatry; 1997; 58 Suppl 10():22-7. PubMed ID: 9265913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neuronal pathology of schizophrenia: molecules and mechanisms.
    Reynolds GP; Harte MK
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):433-6. PubMed ID: 17371293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in the neurobiology of schizophrenia.
    Miyamoto S; LaMantia AS; Duncan GE; Sullivan P; Gilmore JH; Lieberman JA
    Mol Interv; 2003 Feb; 3(1):27-39. PubMed ID: 14993436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of the glutamate, GABA, and dopamine systems in relation to NRH-induced neurotoxicity.
    Benes FM
    Biol Psychiatry; 1995 Dec; 38(12):783-7. PubMed ID: 8750035
    [No Abstract]   [Full Text] [Related]  

  • 5. Biochemistry and the schizophrenia. Old concepts and new hypothesis.
    Berger PA
    J Nerv Ment Dis; 1981 Feb; 169(2):90-9. PubMed ID: 7009786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neural circuitry models of schizophrenia: is it dopamine, GABA, glutamate, or something else?
    Benes FM
    Biol Psychiatry; 2009 Jun; 65(12):1003-5. PubMed ID: 19481640
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hypoglutamatergic hypothesis of schizophrenia: evidence from genetic studies].
    Itokawa M; Yoshikawa T
    Seishin Shinkeigaku Zasshi; 2003; 105(11):1349-62. PubMed ID: 14758783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiologically based treatment interventions in schizophrenia.
    Lewis DA; Gonzalez-Burgos G
    Nat Med; 2006 Sep; 12(9):1016-22. PubMed ID: 16960576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postmortem investigations of the pathophysiology of schizophrenia: the role of susceptibility genes.
    Perlman WR; Weickert CS; Akil M; Kleinman JE
    J Psychiatry Neurosci; 2004 Jul; 29(4):287-93. PubMed ID: 15309045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha7 nicotinic cholinergic neuromodulation may reconcile multiple neurotransmitter hypotheses of schizophrenia.
    Bencherif M; Stachowiak MK; Kucinski AJ; Lippiello PM
    Med Hypotheses; 2012 May; 78(5):594-600. PubMed ID: 22336089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of cortical inhibition in the pathophysiology and treatment of schizophrenia.
    Daskalakis ZJ; Fitzgerald PB; Christensen BK
    Brain Res Rev; 2007 Dec; 56(2):427-42. PubMed ID: 17980435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence.
    Carlsson A; Waters N; Holm-Waters S; Tedroff J; Nilsson M; Carlsson ML
    Annu Rev Pharmacol Toxicol; 2001; 41():237-60. PubMed ID: 11264457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neurodevelopmental model of schizophrenia: update 2005.
    Rapoport JL; Addington AM; Frangou S; Psych MR
    Mol Psychiatry; 2005 May; 10(5):434-49. PubMed ID: 15700048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.
    Javitt DC
    Int Rev Neurobiol; 2007; 78():69-108. PubMed ID: 17349858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating the neurodevelopmental hypothesis of schizophrenia.
    Rehn AE; Rees SM
    Clin Exp Pharmacol Physiol; 2005 Sep; 32(9):687-96. PubMed ID: 16173923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How do glial-neuronal interactions fit into current neurotransmitter hypotheses of schizophrenia?
    Kondziella D; Brenner E; Eyjolfsson EM; Sonnewald U
    Neurochem Int; 2007 Jan; 50(2):291-301. PubMed ID: 17084946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GABA and schizophrenia: a review of basic science and clinical studies.
    Wassef A; Baker J; Kochan LD
    J Clin Psychopharmacol; 2003 Dec; 23(6):601-40. PubMed ID: 14624191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothesis: minimal changes in neural transmission in schizophrenia: decreased glutamatergic and GABAergic functions in the prefrontal cortex.
    Ohnuma T; Suzuki T; Arai H
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):889-94. PubMed ID: 15949884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recent advances in the genetics of schizophrenia and the practical implications of the results].
    Réthelyi J; Polgár P; Czobor P; Bitter I
    Psychiatr Hung; 2008; 23(3):152-65. PubMed ID: 18956622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence.
    Harrison PJ; Weinberger DR
    Mol Psychiatry; 2005 Jan; 10(1):40-68; image 5. PubMed ID: 15263907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.